JUSTIN CHUNG KAY LING

Allopathic & Osteopathic Physicians|Internal Medicine BALTIMORE, MD NPI 1801418397

General Payments — all program years on this page

$578.79

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $461.78 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $461.7821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $117.015
2024 $461.7821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078042604 Janssen Pharmaceuticals, Inc $21.13 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078042892 Janssen Pharmaceuticals, Inc $22.14 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078043092 Janssen Pharmaceuticals, Inc $23.24 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078043194 Janssen Pharmaceuticals, Inc $19.38 07/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078043264 Janssen Pharmaceuticals, Inc $19.99 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078043376 Janssen Pharmaceuticals, Inc $20.30 03/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087148698 Novartis Pharmaceuticals Corporation $25.50 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087148708 Novartis Pharmaceuticals Corporation $20.92 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097195164 Novo Nordisk Inc $22.09 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104886697 ABBVIE INC. $20.40 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104886699 ABBVIE INC. $24.88 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104886701 ABBVIE INC. $22.74 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104886703 ABBVIE INC. $19.26 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127780597 EVOKE PHARMA, INC. $15.03 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139164332 RECORDATI_RARE_DISEASES_INC. $20.35 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139164334 RECORDATI_RARE_DISEASES_INC. $18.62 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141782977 Merck Sharp & Dohme LLC $24.59 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141893368 Merck Sharp & Dohme LLC $22.74 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145099861 Mallinckrodt Hospital Products Inc. $30.45 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153431227 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.01 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153500699 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.02 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.